• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
H.C. Wainwright Maintains Buy Rating on Unicycive with $22 Price Target
11:48
Unicycive Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3327 (forecast USD -0.5333)
04:00
Unicycive Therapeutics released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3585
04:00
Oct31
Jason McCarthy Issues a Buy Rating for Unicycive Therapeutics
07:27
Oct29
Unicycive Plans to Resubmit OLC NDA by Year-End
20:39
Aug15
Unicycive Therapeutics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.49
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.011 M, EPS -0.3327

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.447 M, EPS -0.524

Jun20
Reverse Stock Split(EST)

1-for-10 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More